Publication
Article
Author(s):
The Damon Runyon Cancer Research Foundation awarded a total of $3.6 million to 9 winners of the Damon Runyon-Rachleff Innovation Awards. The grants support investigators whose ideas have the potential to significantly advance the prevention, diagnosis, or treatment of cancer.
The Damon Runyon Cancer Research Foundation awarded a total of $3.6 million to 9 winners of the Damon Runyon-Rachleff Innovation Awards. The grants support investigators whose “high-risk/high-reward” ideas have the potential to significantly advance the prevention, diagnosis, or treatment of cancer.
Four individuals and 1 team will receive 2-year grants of $400,000. Investigators who demonstrate noteworthy progress during the first 2 years of research will receive 2 additional years of funding.
Venture capitalist Andrew S. Rachleff and his wife, Debra Rachleff, established the award to promote exceptionally creative thinkers who have an innovative idea “but lack sufficient preliminary data to obtain traditional funding.” A committee of leading cancer researchers selects the winners among applicants whose passion for curing cancer is clear.